Skip to main content

Transforming the understanding
and treatment of mental illnesses.

Celebrating 75 Years! Learn More >>

 Archived Content

The National Institute of Mental Health archives materials that are over 4 years old and no longer being updated. The content on this page is provided for historical reference purposes only and may not reflect current knowledge or information.

Three NIH Scientists Elected into IOM

Science Update

The National Institute of Mental Health (NIMH) congratulates Daniel S. Pine, M.D., one of three NIH scientists  elected as members of the prestigious Institute of Medicine (IOM). Dr. Pine is the chief of the Section on Development and Affective Neuroscience in the NIMH Intramural Research Program.

Election to the IOM  is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. Current, active IOM membership elects new members annually from candidates nominated for professional achievement and commitment to service. “Selection to the IOM is a marker of an outstanding scientific career,” said NIH Director Francis S. Collins, M.D., Ph.D. “We are proud of our accomplished scientists and congratulate them on this honor.”

NIMH Researcher Daniel S. Pine, M.D.

After graduating from medical school at the University of Chicago in 1990, Dr. Pine spent 10 years in training and research on child psychiatry at the College of Physicians and Surgeons of Columbia University, New York City. Since medical school, he has been engaged continuously in research focusing on the epidemiology, biology, and treatment of pediatric mental illnesses. His areas of expertise include biological and pharmacological aspects of mood, anxiety, and behavioral disorders in children, as well as classification of psychopathology across the lifespan. This expertise is reflected in more than 300 peer-reviewed papers. Currently, his research group is examining the degree to which mood and anxiety disorders in children and adolescents are associated with underlying abnormalities in the amygdala, prefrontal cortex, and associated brain regions.